![](https://investorshub.advfn.com/uicon/515354.png?cb=1605015277)
Wednesday, April 15, 2020 11:02:06 AM
My reasoning is laid out in an earlier, EZ to read and understand post based primarily on NOT WHAT I THINK, but words directly from Dr. Mark Williams.
Doc Williams has a PhD and MBA. He's the mastermind of Algernon's repurposed drug strategy for multiple compounds including leading compound NP-120 Ifenprodil.
What Doc Williams stated in the BioPub webcast just 2 DAY AGO is NP-120 has a shot at going straight to market DURING THE PHASE 2 clinical trial. He even stated Algernon has biostatisticians looking at that very possibility.
If that happens there will be no NASDAQ or march to $3, $4, $5, $25...
Algernon will get bought out - PERIOD.
But hey, don't pay me no nevermind. I just go through the information they put forth as respect to what their doing for my investment AND to know what the F*** is actually going on with the company and my money.
Watch This Space >`
![](http://investorshub.advfn.com/uimage/uploads/2019/7/20/srrtmAlgernauts.gif)
/////AMG
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM